BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17525828)

  • 21. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
    Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
    Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
    Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
    Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
    De Chiara L; Páez de la Cadena M; Rodríguez-Berrocal J; Alvarez-Pardiñas MC; Pardiñas-Añón MC; Varela-Calviño R; Cordero OJ
    Dis Markers; 2020; 2020():4347936. PubMed ID: 32051696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
    Oki S; Miyake S
    Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals.
    Hosono O; Homma T; Kobayashi H; Munakata Y; Nojima Y; Iwamoto A; Morimoto C
    Clin Immunol; 1999 Jun; 91(3):283-95. PubMed ID: 10370373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th2 cell differentiation from naive CD4
    Hirata H; Yukawa T; Tanaka A; Miyao T; Fukuda T; Fukushima Y; Kurasawa K; Arima M
    Clin Exp Allergy; 2019 Apr; 49(4):474-483. PubMed ID: 30431203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
    Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH
    Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis.
    Bock O; Kreiselmeyer I; Mrowietz U
    Exp Dermatol; 2001 Dec; 10(6):414-9. PubMed ID: 11737260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma.
    Grob M; Schmid-Grendelmeier P; Joller-Jemelka HI; Ludwig E; Dubs RW; Grob PJ; Wüthrich B; Bisset LR
    Allergy; 2003 Mar; 58(3):239-45. PubMed ID: 12653799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
    Martinez-Navio JM; Climent N; Pacheco R; Garcia F; Plana M; Nomdedeu M; Oliva H; Rovira C; Miralles L; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
    Immunology; 2009 Nov; 128(3):393-404. PubMed ID: 20067539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
    Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
    Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
    Ruiz P; Zacharievich N; Shenkin M
    Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
    Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
    J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
    Söderholm J; Waldenström J; Askarieh G; Pilli M; Bochud PY; Negro F; Pawlotsky JM; Zeuzem S; Ferrari C; Norkrans G; Wejstål R; Westin J; Neumann AU; Haagmans BL; Lindh M; Missale G; Hellstrand K; Lagging M
    PLoS One; 2013; 8(2):e56991. PubMed ID: 23437290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human CD26
    Bailey SR; Nelson MH; Majchrzak K; Bowers JS; Wyatt MM; Smith AS; Neal LR; Shirai K; Carpenito C; June CH; Zilliox MJ; Paulos CM
    Nat Commun; 2017 Dec; 8(1):1961. PubMed ID: 29213079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of inhaled ciclesonide on circulating T-helper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge.
    Kawayama T; O'Byrne PM; Watson RM; Killian KJ; Duong M; Yoshida M; Gauvreau GM
    Clin Exp Allergy; 2006 Nov; 36(11):1417-24. PubMed ID: 17083352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired IL-10-dependent induction of tolerogenic dendritic cells by CD4+CD25hiCD127lo/- natural regulatory T cells in human allergic asthma.
    Nguyen KD; Vanichsarn C; Nadeau KC
    Am J Respir Crit Care Med; 2009 Nov; 180(9):823-33. PubMed ID: 19679691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.